11/30
03:33 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at
Wall Str
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at
Wall Str
11/20
06:02 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/14
08:10 am
mrkr
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
11/14
07:00 am
mrkr
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Medium
Report
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
11/5
07:30 am
mrkr
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Low
Report
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
11/3
09:15 am
mrkr
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
Low
Report
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
10/6
07:39 am
mrkr
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program [Yahoo! Finance]
Medium
Report
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program [Yahoo! Finance]
10/6
07:30 am
mrkr
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
Medium
Report
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program